Verlingue, L. et al. 2024. The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST. Acta Oncologica. 63, 1 (May 2024), 411–417. DOI:https://doi.org/10.2340/1651-226X.2024.32745.